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Sir,
Legislation and professional guidance on confidentiality in
medical research has increased significantly in the past 10 years
(Stiller, 1993; Working Group to the Royal College of Physicians
Committee on Ethical Issues in Medicine, 1994; European
Parliament, 1995; The Caldicott Committee, 1997; Department of
Health, 1999; General Medical Council, 2000; Medical Research
Council, 2000; Coker and McKee, 2001; Confidentiality and
Security Advisory Group for Scotland, 2002; Council for Inter-
national Organizations of Medical Sciences, 2002; Information
Commissioner, 2002).
Numerous reports have been issued by national and inter-
national bodies (Lowrance, 1997; National Health and Medical
Research Council, 1999; Canadian Institutes of Health Research,
2001; Organisation for Economic Co-operation and Development,
2001; Council for International Organizations of Medical Sciences,
2002; Lowrance, 2002; Nuffield Council on Bioethics, 2002; World
Medical Association, 2002a, b; Medical Research Council, 2003;
National Institutes of Health, 2004).
There is very wide debate over the appropriate balance to be
struck between increasing demands for personal autonomy, on the
one hand, and, on the other, the need for society to learn from the
experience of individual patients, in order to understand how best
to control disease – this is also in the interests of individuals. The
debate has often focused on the confidentiality of individual health
data and the need for informed consent before such data can be
used in research (Vandenbroucke, 1992; Vanchieri, 1993; Strobl
et al, 2000; Anderson, 2001; Bastian, 2001; Doll, 2001; Doll and
Peto, 2001; Cassell and Young, 2002; Greenberg, 2002; Kulynych
and Korn, 2002a, b; Verity and Nicoll, 2002; Coleman et al, 2003;
De Vet et al, 2003; Ingelfinger and Drazen, 2004; Peto et al, 2004;
Tu et al, 2004; Robling et al, 2005).
The International Association of Cancer Registries (IACR)
published guidance on confidentiality for cancer registries in the
British Journal of Cancer in 1992 (Coleman et al, 1992). Some
national and regional cancer registry associations incorporated
the IACR guidance in their own guidelines. At the IACR scientific
meeting in Tampere, Finland, in 2002, it was decided to update the
guidance. A review seemed appropriate after 10 years. European
Union (EU) legislation on the protection of personal data had
come into force in all member states during this period, and
the EU Directive (European Parliament, 1995) has served as a
model for national legislation in many countries outside Europe.
Rapid developments in web-based communication also motivated
revision of the guidance, with a view to appropriate use of
this technology, with the attendant risks of breach of confiden-
tiality. The guidance was revised by a small group, endorsed by
the IACR Board in 2004, and made available at www.iacr.com.fr/
confidentiality2004.pdf.
The main changes from the previous version are:
 a clear description of the principles of confidentiality, as they
relate to identifiable data and the registration of cancer;
 an update of measures to protect data confidentiality;
 guidance on security for both traditional paper-based systems
and modern electronically based data systems; and
 expanded recommendations designed to ensure confidentiality
in data releases for research, including cross-border transfers.
The updated IACR guidance on confidentiality in the cancer
registry should help the cancer research community continue to
provide useful information on the causes, treatment and outcome
of cancer in the entire population, while maintaining the highest
ethical standards in confidential data collection and research.
REFERENCES
Anderson R (2001) Undermining data privacy in health information. Br
Med J 322: 422 – 423
Bastian H (2001) What are the effects of the fifth revision of the Declaration
of Helsinki? Gains and losses for rights of consumer and research
participants. Br Med J 323: 1419 – 1421
Canadian Institutes of Health Research (2001) Selected International Legal
Norms on the Protection of Personal Information in Health Research.
Ottawa: CIHR
Cassell J, Young A (2002) Why we should not seek individual informed
consent for participation in health services research. J Med Ethics 28:
313 – 317
Coker R, McKee M (2001) Ethical approval for health research in
central and eastern Europe: an international survey. Clin Med 1:
197 – 199
*Correspondence: Dr H Storm; E-mail: hans@cancer.dk
Published online 10 May 2005
British Journal of Cancer (2005) 92, 2095 – 2096
& 2005 Cancer Research UK All rights reserved 0007 – 0920/05 $30.00
www.bjcancer.com
Coleman MP, Evans BG, Barrett G (2003) Confidentiality and the
public interest in medical research – will we ever get it right? Clin Med
3: 219 – 228
Coleman MP, Muir CS, Me´ne´goz F (1992) Confidentiality in the cancer
registry. Br J Cancer 66: 1138 – 1149
Confidentiality and Security Advisory Group for Scotland (2002) Protecting
Patient Confidentiality: Final Report. Edinburgh: Confidentiality and
Security Advisory Group for Scotland
Council for International Organizations of Medical Sciences (2002)
International Ethical Guidelines for Biomedical Research Involving
Human Subjects. Geneva: CIOMS
De Vet HCW, Dekker JM, van Ven EB, Olsen J (2003) Access to data from
European registries for epidemiological research: results from a survey
by the International Epidemiological Association European Federation.
Int J Epidemiol 32: 1114 – 1115
Department of Health (1999) Protecting and Using Patient Information: a
Manual for Caldicott Guardians. London: Department of Health
Doll R (2001) What are the effects of the fifth revision of the Declaration of
Helsinki? Research will be impeded. Br Med J 323: 1421 – 1422
Doll R, Peto R (2001) Rights involve responsibilities for patients. Br Med J
322: 730
European Parliament (1995) Protection of individuals with regard to the
processing of personal data and on the free movement of such data.
Directive 95/46/EC, 0031 – 0050. 24-10-1995
General Medical Council (2000) Statement on confidentiality and cancer
registries (8 November 2000). General Medical Council. 8-11-2000
Greenberg DS (2002) US Senate weighs proposal on medical privacy. Lancet
359: 1585
Information Commissioner (2002) Use and disclosure of health data:
guidance on the application of the Data Protection Act 1998. Wilmslow:
Cheshire, Information Commission
Ingelfinger JR, Drazen JM (2004) Registry research and medical privacy.
N Engl J Med 350: 1452 – 1453
Kulynych J, Korn D (2002a) The new federal medical-privacy rule. N Engl J
Med 347: 1133 – 1134
Kulynych J, Korn D (2002b) The effect of the new federal medical-privacy
rule on research. N Engl J Med 346: 201 – 204
Lowrance WW (1997) Privacy and health research. A Report to the US
Secretary of Health and Human Services. Washington DC: DHHS
Lowrance WW (2002) Learning From Experience: Privacy and the
Secondary Use of Data in Health Research. London: Nuffield Trust
Medical Research Council (2000) Personal information in medical research.
MRC Ethics Series. London: Medical Research Council
Medical Research Council, Natural Sciences and Engineering Research
Council and Social Sciences and Humanities Research Council of Canada
(2003) Tri-Council Policy Statement: Ethical Conduct for Research
Involving Humans. Ottawa
National Health and Medical Research Council (1999) National Statement
on Ethical Conduct in Research Involving Humans. Canberra: Common-
wealth of Australia
National Institutes of Health (2004) Research Repositories, Databases and
the HIPAA Privacy Rule. Bethesda MD: NIH
Nuffield Council on Bioethics (2002) The Ethics of Research Related to
Healthcare in Developing Countries. London: Nuffield Council on
Bioethics
Organisation for Economic Co-operation and Development (2001) OECD
Guidelines on the Protection of Privacy and Transborder Flows of
Personal Data. Paris: OECD
Peto J, Fletcher O, Gilham C (2004) Data protection, informed consent and
research. Medical research suffers because of pointless obstacles. Br Med
J 328: 1029 – 1030
Robling MR, Hood K, Pill R, Fay J, Evans HM (2005) Public attitudes
towards the use of primary care patient record data in medical research
without consent: a qualitative study. J Med Ethics 30: 104 – 109
Stiller CA (1993) Cancer registration: its uses in research, and confidenti-
ality in the EC. J Epidemiol Comm Hlth 47: 342 – 344
Strobl J, Cave E, Walley T (2000) Data protection legislation: interpretation
and barriers to research. Br Med J 321: 890 – 892
The Caldicott Committee (1997) Report on the Review of Patient-
Identifiable Information. London: Department of Health
Tu JV, Willison DJ, Silver FL, Fang J, Richards JA, Laupacis A, Kapral MK,
Investigators in the Registry of the Canadian Stroke Network (2004)
Impracticability of informed consent in the registry of the Canadian
Stroke Network. N Engl J Med 350: 1414 – 1421
Vanchieri C (1993) New EC privacy directive worries European epidemiol-
ogists. J Natl Cancer Inst 85: 1022 – 1023
Vandenbroucke JP (1992) Privacy, confidentiality and epidemiology: the
Dutch ordeal. Int J Epidemiol 21: 825 – 826
Verity C, Nicoll A (2002) Consent, confidentiality, and the threat to public
health surveillance. Br Med J 324: 1210 – 1213
Working Group to the Royal College of Physicians Committee on
Ethical Issues in Medicine (1994) Independent ethical review of
studies involving personal medical records. J Roy Coll Physic (London)
28: 439 – 443
World Medical Association (2002a) The World Medical Association
Declaration on Ethical Considerations Regarding Health Databases.
Geneva: CIOMS
World Medical Association (2002b) Declaration of Helsinki. Ethical
Principles for Medical Research involving Human Subjects. Ferney-
Voltaire: WMA
Letter to the Editor
2096
British Journal of Cancer (2005) 92(11), 2095 – 2096 & 2005 Cancer Research UK
